Fibrinogen Concentrate Compared to Cryoprecipitate to Reduce Transfusion in Infants Undergoing Cardiac Surgery: How Confident Can We Be?
- PMID: 33031678
- DOI: 10.1213/ANE.0000000000004885
Fibrinogen Concentrate Compared to Cryoprecipitate to Reduce Transfusion in Infants Undergoing Cardiac Surgery: How Confident Can We Be?
Comment in
-
In Response.Anesth Analg. 2020 Aug;131(2):e84-e86. doi: 10.1213/ANE.0000000000004886. Anesth Analg. 2020. PMID: 33031679 No abstract available.
Comment on
-
Fibrinogen Concentrate as an Alternative to Cryoprecipitate in a Postcardiopulmonary Transfusion Algorithm in Infants Undergoing Cardiac Surgery: A Prospective Randomized Controlled Trial.Anesth Analg. 2020 Mar;130(3):740-751. doi: 10.1213/ANE.0000000000004384. Anesth Analg. 2020. PMID: 31490252 Clinical Trial.
References
-
- Downey LA, Andrews J, Hedlin H, et al.Fibrinogen concentrate as an alternative to cryoprecipitate in a postcardiopulmonary transfusion algorithm in infants undergoing cardiac surgery: a prospective randomized controlled trial. Anesth Analg. 2020;130:740–751.
-
- Callum J, Farkouh ME, Scales DC, et al.Effect of fibrinogen concentrate vs cryoprecipitate on blood component transfusion after cardiac surgery: the FIBRES randomized clinical trial. JAMA. 2019;322:1966–1976.
-
- Downey LA, Williams GDRepurposing of fibrinogen concentrate as a cost-effective and safe hemostatic agent in infants undergoing cardiac surgery on cardiopulmonary bypass. Available at: https://clinicaltrials.gov/ProvidedDocs/00/NCT03014700/Prot_000.pdf. Accessed May 11, 2020.
-
- Kahan BC, Morris TPAnalysis of multicentre trials with continuous outcomes: when and how should we account for centre effects? Stat Med. 2013;32:1136–1149.
-
- Jones PM, Bryson GLOpen season: positive changes for increased transparency in the biomedical literature. Can J Anaesth. 2018;65:246–253.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
